Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNLIGHT: Trifluridine/Tipiracil + Bevacizumab in Refractory mCRC
NCT04737187Phase 3Completed
- Sponsor
- Taiho Oncology
- Start
- Nov 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of trifluridine + tipiracil in metastatic colorectal cancer (mCRC), sponsored by Taiho Oncology. Started Nov 2020; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT04737187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04737187.